Vaccine-associated Paralytic Poliomyelitis in Immunodeficient Children, Iran, 1995–2008

To determine the prevalence of vaccine-associated paralytic poliomyelitis (VAPP) in immunodeficient infants, we reviewed all documented cases caused by immunodeficiency-associated vaccine-derived polioviruses in Iran from 1995 through 2008. Changing to an inactivated polio vaccine vaccination schedu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahmahmoodi, Shohreh, Mamishi, Setareh, Aghamohammadi, Asghar, Aghazadeh, Nessa, Tabatabaie, Hamideh, Gooya, Mohammad Mehdi, Zahraei, Seyed Mohsen, Mousavi, Taha, Yousefi, Maryam, Farrokhi, Kobra, Mohammadpour, Masoud, Ashrafi, Mahmoud Reza, Nategh, Rakhshandeh, Parvaneh, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2010
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321898/
https://www.ncbi.nlm.nih.gov/pubmed/20587188
http://dx.doi.org/10.3201/eid1607.091606
Descripción
Sumario:To determine the prevalence of vaccine-associated paralytic poliomyelitis (VAPP) in immunodeficient infants, we reviewed all documented cases caused by immunodeficiency-associated vaccine-derived polioviruses in Iran from 1995 through 2008. Changing to an inactivated polio vaccine vaccination schedule and introduction of screening of neonates for immunodeficiencies could reduce the risk for VAPP infection.

Ejemplares similares